newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics to Participate in the Jefferies Cell and Genetic Medicine Summit

BOSTON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Lau